Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-10 of 45

Journal Article

08/02/2023

Maternal mRNA COVID-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study

Jorgensen SCJ, Hernandez A, Fell DB, Austin PC, D’Souza R, Guttmann A, Brown KA, Buchan SA, Gubbay JB, Nasreen S, Schwartz KL, Tadrous M, Wilson K, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network. BMJ. 2023; 380:e074035. Epub 2023 Feb 8.

Journal Article

03/12/2022

Effectiveness and duration of protection of a fourth dose of Coronavirus disease 2019 messenger RNA vaccine among long-term care residents in Ontario, Canada

Grewal R, Nguyen L, Buchan SA, Wilson SE, Costa AP, Kwong JC. J Infect Dis. 2023; 227(8):977–80. Epub 2022 Dec 3.

Journal Article

18/10/2022

Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV

Chambers C, Samji H, Cooper CL, Costiniuk CT, Janjua NZ, Kroch AE, Arbess G, Benoit AC, Buchan SA, Chung H, Kendall CE, Kwong JC, Langlois MA, Lee SM, Mbuagbaw L, Mccullagh J, Moineddin R, Nambiar D, Walmsley S, Anis A, Burchell AN. AIDS. 2022; Oct 18 [Epub ahead of print].

Journal Article

22/09/2022

Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. JAMA Netw Open. 2022; 5(9):e2232760. Epub 2022 Sep 22.

Journal Article

07/09/2022

Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study

Chung H, Austin PC, Brown KA, Buchan SA, Fell DB, Fong C, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Open Forum Infect Dis. 2022; Sep 7 [Epub ahead of print].

Journal Article

17/08/2022

Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: a multiprovincial test-negative design study

Nasreen S, Febriani Y, García HAV, Zhang G, Tadrous M, Buchan SA, Righolt CH, Mahmud SM, Janjua NZ, Krajden M, De Serres G, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Clin Infect Dis. 2022; Aug 17 [Epub ahead of print].

Journal Article

06/07/2022

Effectiveness of a fourth dose of COVID-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study

Grewal R, Kitchen SA, Nguyen L, Buchan SA, Wilson SE, Costa AP, Kwong JC. BMJ. 2022; 378:e071502. Epub 2022 Jul 6.

Journal Article

16/06/2022

Vaccine effectiveness of BNT162b2 against Delta and Omicron variants in adolescents

Buchan SA, Nguyen L, Wilson SE, Kitchen SA, Kwong JC. Pediatrics. 2022; Jun 16 [Epub ahead of print].

Journal Article

27/04/2022

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network CIRN Provincial Collaborative Network PCN Ontario investigators. Vaccine. 2022; 40(24):3305-12. Epub 2022 Apr 27.

Journal Article

29/03/2022

Screening large population health databases for potential coronavirus disease 2019 therapeutics: a pharmacopeia-wide association study of commonly prescribed medications

MacFadden DR, Brown K, Buchan SA, Chung H, Kozak R, Kwong JC, Manuel D, Mubareka S, Daneman N. Open Forum Infect Dis. 2022; 9(5):ofac156. Epub 2022 Mar 29.

« Previous 1 2 3 4 5 Next »

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

Maternal mRNA COVID-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study

Effectiveness and duration of protection of a fourth dose of Coronavirus disease 2019 messenger RNA vaccine among long-term care residents in Ontario, Canada

Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV

Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study

Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: a multiprovincial test-negative design study

Effectiveness of a fourth dose of COVID-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study

Vaccine effectiveness of BNT162b2 against Delta and Omicron variants in adolescents

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

Screening large population health databases for potential coronavirus disease 2019 therapeutics: a pharmacopeia-wide association study of commonly prescribed medications